Stool samples obtained from 594 Senegalese patients were examined for characterization of pathogenic Escherichia coli in human immunodeficiency virus (HIV)-related diarrhea. Multiple virulence genes were observed in stool samples obtained from HIV-infected patients with diarrhea. Enteroaggregative E. coli and enteroinvasive E. coli were present in stool samples obtained from patients with diarrhea significantly more often than in stool samples obtained from patients without diarrhea ( ). Quinolones may be P p .000001 an effective alternative treatment for E. coli-related diarrhea in HIV-infected adults in Senegal.
It has been proven that persistent diarrhea is responsible for a substantial proportion of diarrhea-associated morbidity and mortality in human immunodeficiency virus (HIV)-infected (HIV + ) patients, particularly in those with AIDS. In developing countries, diarrhea is common, occurring in 60%-90% of HIV + patients [1] . HIV itself has been associated with enteropathy in patients with AIDS [2] . Alteration of the lamina propria predisposes these patients to enteric infections; as a result, they are susceptible to low doses of some pathogens, which would produce only asymptomatic or mild infection in immunocompetent hosts.
Among enteric pathogens, Escherichia coli has been recognized as being strongly associated with persistent diarrhea; this versatile organism has different virulence factors (e.g., adhesins, invasins, and toxins) that are responsible for a wide range of types of diarrheal disease [3, 4] . Six categories of diarrhegenic E. coli are defined by the presence of specific genes that encode for their virulence factors: LT (heat-labile enterotoxin) and Sta (heat-stable enterotoxin), which encode enterotoxigenic E. coli; eaeA (E. coli attaching and effacing) and bfpA (bundle-forming pilus), which encode enteropathogenic E. coli (EPEC); ipaH (invasion plasmid antigen H), which encodes enteroinvasive E. coli (EIEC); SLTI (Shiga-like toxin I) and SLTII (Shiga-like toxin II), which encode enterohemorragic E. coli (EHEC); Eagg, which encodes enteroaggregative E. coli (EaggEC); and afa (afimbrial adhesin), which encodes diffusely adherent E. coli (DAEC) [5] . To our knowledge, this is the first study conducted in Senegal to identify pathogenic E. coli in HIV-related diarrhea.
We 
. The aim of the present study was to characterize virulence genes in pathogenic E. coli, to determine the adherence phenotypes, and to evaluate the current antimicrobial-susceptibility patterns of virulent strains. We hoped that our findings would help identify an appropriate treatment that could significantly alleviate morbidity associated with diarrhea in HIV + patients. Patients and methods. From June 1997 through December 1999, stool and blood samples were obtained from patients 118 years old who were hospitalized in a university teaching hospital-based infectious diseases clinic (Centre Hospitalier Universitaire Fann) and in an urban hospital (Hôpital Principal) in Dakar. Written, informed consent was obtained from all participants, and all aspects of the study were approved by the ad hoc Ethical Committee. These subjects were randomly selected to be part of a case-control study of HIV-associated diarrhea ( 
Multiple virulence genes ulence gene was identified on at least 3 of 5 tested colonies. Five colonies of E. coli obtained as a pure culture were selected by standard biochemical tests (API 20E; Bio Mérieux). DNA was extracted by boiling and was stored at Ϫ20ЊC. Virulence factors were screened by use of polymerase chain reaction (PCR) using the following primers: eaeA (5 -GCA AAT TTA  GGT GCG GGT CAG CGT T-3 and 5 -GGC TCA ATT TGC  TGA GAC CAC GGT T- Amplified DNA products were resolved by conventional electrophoresis. All PCR amplifications were performed in duplicate. E. coli adherence pattern was assayed in Hep-2 cells, as described by Cravioto et al. [6] . Positive and negative controls were included in each assay. All assays were blind-read by 2 investigators. Antimicrobial-susceptibility testing was done by the disk-diffusion method on Mueller Hinton agar (Becton Dickinson) with commercial antimicrobial disks (Sanofi Diagnostics Pasteur), in accordance with NCCLS guidelines [7] .
HIV Results of the HEp-2 cell adherence assay show 3 morphologic patterns. DAEC was the most frequent pattern and was not isolated from case and control patients at different frequencies. The enteroaggregative and localized HEp-2 adherent patterns were displayed more often by E. coli strains isolated from D + HIV + patients. Virulent strains were found to be resistant to at least 4 antibiotics, including trimethoprim-sulfamethoxazole, aminopenicillin, carboxypenicillin, and tetracycline. Of the EIEC strains, 67% were resistant to aminopenicillin, carboxypenicillin, and trimethoprim-sulfamethoxazole; 22% were resistant to amoxicillin-clavulanic acid; and 89% were resistant to tetracycline. Of the EaggEC strains, 85% were resistant to aminopenicillin, 56% were resistant to carboxypenicillin, 30% were resistant to amoxicillin-clavulanic acid, 78% were resistant to trimethoprim-sulfamethoxazole, and 96% were resistant to tetracycline. No strain was resistant to quinolone.
Discussion. In Africa, chronic diarrhea is common among HIV + patients and is associated with high rates of morbidity and mortality. The lower CD4 lymphocyte counts in D + HIV + patients show that diarrhea itself is a debilitating illness and suggest that effective management of the diarrhea can prevent immunosuppression. EaggEC is recognized as an emerging cause of diarrhea in HIV + patients. It was often found in immunocompromised D + patients [8] and can be considered as an opportunistic pathogen. The present study confirms the association between persistent diarrhea and EaggEC previously suspected in other countries [9] . EaggEC has been identified by "stacked brick" adherence to tissue culture cells. However, some of our isolates from D + HIV + patients displayed the "stacked brick" aggregative adherence pattern on HEp-2 cells but lacked the typical virulence factor of EaggEC strains. This phenomenon has been observed by other investigators and highlights the necessity to look for other virulence factors [10, 11] .
Isolation of EIEC was not dependent on HIV serostatus, and no asymptomatic carriage was found for this pathogen. Data are scarce with regard to an association between EIEC and diarrhea during HIV infection; a survey of fecal flora in 182 stool samples from 95 HIV + patients has not detected any isolates of EIEC, but the research has shown that EIEC causes recurrent bacteremia [12] .
The high frequency of the afa gene in our control patients suggests that pathogenic E. coli were those strains with at least 1 virulence factor other than the afa gene. This finding reveals that, in Senegal, there is no evidence for a role of enteroadherent E. coli in diarrhea in HIV + patients, as demonstrated by another study conducted in The Netherlands [13] . Further investigations would be useful in determining whether the afa gene acts as a cofactor for other virulence genes. For many years, EPEC strains have been known to be important enteropathogens in children [14] , and now they have emerged as being important enteropathogens in immunocompromised adults.
The high frequency of resistance to cotrimoxazole and tetracycline among EaggEC and EIEC strains could be explained by the selective pressure to which strains are exposed: in Senegal, tetracyclines and cotrimoxazole are used extensively for the treatment of diarrhea. These data exclude these 2 groups of antibiotics and make quinolones the drug of choice in treating diarrhea.
To our knowledge, this is the first study in which EaggEC strains were identified as etiologic agents of diarrhea in Senegal; it has revealed clearly the role of EaggEC in causing diarrhea in HIV + adults. EaggEC strains seem to be heterogeneous; as a result, virulence factors should be evaluated and updated, with the aim of developing new diagnostic methods for this organism. Simultaneous resistance to 11 antibiotic, as shown by our data, is an alarming problem for the management of these diarrheas. A study of genetic antibiotic-resistance pattern would be very useful in determining the resistance mechanisms for these antibiotics of this widespread species (E. coli) and may ultimately help us establish new strategies to reduce morbidity and mortality associated with infectious diseases.
